Global burden and epidemiology of Barrett oesophagus and oesophageal cancer (original) (raw)

• World Health Organization. Cancer Today: Data visualization tools for exploring the global cancer burden in 2020. https://gco.iarc.fr/today/home (2020).
• Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
  Article PubMed Google Scholar
• Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7–34 (2019).
  Article PubMed Google Scholar
• Thrift, A. P. Barrett’s esophagus and esophageal adenocarcinoma: how common are they really? Dig. Dis. Sci. 63, 1988–1996 (2018).
  Article PubMed Google Scholar
• Anderson, L. A. et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5. Eur. J. Cancer 51, 2144–2157 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Arnold, M., Soerjomataram, I., Ferlay, J. & Forman, D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64, 381–387 (2015).
  Article PubMed Google Scholar
• Pohl, H. & Welch, H. G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl Cancer Inst. 97, 142–146 (2005).
  Article PubMed Google Scholar
• Thrift, A. P. & Whiteman, D. C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann. Oncol. 23, 3155–3162 (2012).
  Article CAS PubMed Google Scholar
• Edgren, G., Adami, H. O., Weiderpass, E. & Nyren, O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 62, 1406–1414 (2013).
  Article PubMed Google Scholar
• Kendall, B. J. & Whiteman, D. C. Temporal changes in the endoscopic frequency of new cases of Barrett’s esophagus in an Australian health region. Am. J. Gastroenterol. 101, 1178–1182 (2006).
  Article PubMed Google Scholar
• Dong, J., Gu, X., El-Serag, H. B. & Thrift, A. P. Underuse of surgery accounts for racial disparities in esophageal cancer survival times: a matched cohort study. Clin. Gastroenterol. Hepatol. 17, 657–665 (2019).
  Article PubMed Google Scholar
• Bray, F. et al. (eds) Cancer Incidence in Five Continents, Vol. XI (Electronic Version) (International Agency for Research on Cancer, 2017).
• Arnold, M., Laversanne, M., Brown, L. M., Devesa, S. S. & Bray, F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am. J. Gastroenterol. 112, 1247–1255 (2017).
  Article PubMed Google Scholar
• Offman, J., Pesola, F. & Sasieni, P. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037. Br. J. Cancer 118, 1391–1398 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Q. L., Xie, S. H., Wahlin, K. & Lagergren, J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin. Epidemiol. 10, 717–728 (2018).
  Article PubMed PubMed Central Google Scholar
• Xie, S. H. & Lagergren, J. A global assessment of the male predominance in esophageal adenocarcinoma. Oncotarget 7, 38876–38883 (2016).
  Article PubMed PubMed Central Google Scholar
• Xie, S. H. & Lagergren, J. The male predominance in esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 14, 338–347 (2016).
  Article PubMed Google Scholar
• Thrift, A. P. & El-Serag, H. B. Sex and racial disparity in incidence of esophageal adenocarcinoma: observations and explanations. Clin. Gastroenterol. Hepatol. 14, 330–332 (2016).
  Article PubMed Google Scholar
• Cook, M. B., Chow, W. H. & Devesa, S. S. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br. J. Cancer 101, 855–859 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cook, M. B., Wild, C. P. & Forman, D. A systematic review and meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am. J. Epidemiol. 162, 1050–1061 (2005).
  Article CAS PubMed Google Scholar
• Xie, S. H. & Lagergren, J. Social group disparities in the incidence and prognosis of oesophageal cancer. U Eur. Gastroenterol. J. 6, 343–348 (2018).
  Article Google Scholar
• Launoy, G., Bossard, N., Castro, C. & Manfredi, S. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur. J. Cancer Prev. 26, S24–S31 (2017).
  Article PubMed Google Scholar
• Surveillance, Epidemiology, and End Rresults Program. SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2018 Sub (1975-2016) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the2018 submission (National Cancer Institute, 2020).
• Thrift, A. P. The epidemic of oesophageal carcinoma: where are we now? Cancer Epidemiol. 41, 88–95 (2016).
  Article PubMed Google Scholar
• Steyerberg, E. W., Earle, C. C., Neville, B. A. & Weeks, J. C. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J. Clin. Oncol. 23, 510–517 (2005).
  Article PubMed Google Scholar
• Spechler, S. J. Clinical practice. Barrett’s esophagus. N. Engl. J. Med. 346, 836–842 (2002).
  Article PubMed Google Scholar
• Ronkainen, J. et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825–1831 (2005).
  Article PubMed Google Scholar
• Cook, M. B. et al. Cancer incidence and mortality risks in a large US Barrett’s oesophagus cohort. Gut 67, 418–529 (2018).
  Article PubMed Google Scholar
• Desai, T. K. et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut 61, 970–976 (2012).
  Article PubMed Google Scholar
• Rastogi, A. et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest. Endosc. 67, 394–398 (2008).
  Article PubMed Google Scholar
• Engel, L. S. et al. Population attributable risks of esophageal and gastric cancers. J. Natl Cancer Inst. 95, 1404–1413 (2003).
  Article PubMed Google Scholar
• Olsen, C. M., Pandeya, N., Green, A. C., Webb, P. M. & Whiteman, D. C. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am. J. Epidemiol. 174, 582–590 (2011).
  Article PubMed Google Scholar
• Hazelton, W. D. et al. The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 24, 1012–1023 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Pandeya, N., Olsen, C. M. & Whiteman, D. C. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol. 37, 579–584 (2013).
  Article CAS PubMed Google Scholar
• Sheikh, M. et al. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan Cohort Study. Gastroenterology 156, 1416–1427 (2019).
  Article PubMed PubMed Central Google Scholar
• Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825–831 (1999).
  Article CAS PubMed Google Scholar
• Cook, M. B. et al. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON). PLoS ONE 9, e103508 (2014).
  Article PubMed PubMed Central Google Scholar
• Thrift, A. P., Kramer, J. R., Qureshi, Z., Richardson, P. A. & El-Serag, H. B. Age at onset of GERD symptoms predicts risk of Barrett’s esophagus. Am. J. Gastroenterol. 108, 915–922 (2013).
  Article PubMed PubMed Central Google Scholar
• Yoshida, N. Inflammation and oxidative stress in gastroesophageal reflux disease. J. Clin. Biochem. Nutr. 40, 13–23 (2007).
  Article CAS PubMed Google Scholar
• Cook, M. B. et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J. Natl Cancer Inst. 102, 1344–1353 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Steevens, J., Schouten, L. J., Goldbohm, R. A. & van den Brandt, P. A. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 59, 39–48 (2010).
  Article CAS PubMed Google Scholar
• Wang, Q. L., Xie, S. H., Li, W. T. & Lagergren, J. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. J. Natl Cancer Inst. 109, djx115 (2017).
  Article Google Scholar
• Pandeya, N. et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am. J. Epidemiol. 168, 105–114 (2008).
  Article PubMed Google Scholar
• Prabhu, A., Obi, K. O. & Rubenstein, J. H. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am. J. Gastroenterol. 109, 822–827 (2014).
  Article PubMed Google Scholar
• Wang, J. B. et al. Attributable causes of esophageal cancer incidence and mortality in China. PLoS ONE 7, e42281 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dar, N. A. et al. Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br. J. Cancer 107, 1618–1623 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cook, M. B. et al. Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium. Gastroenterology 142, 744–753 (2012).
  Article PubMed PubMed Central Google Scholar
• Smith, K. J., O’Brien, S. M., Green, A. C., Webb, P. M. & Whiteman, D. C. Current and past smoking significantly increase risk for Barrett’s esophagus. Clin. Gastroenterol. Hepatol. 7, 840–848 (2009).
  Article PubMed Google Scholar
• Edelstein, Z. R., Farrow, D. C., Bronner, M. P., Rosen, S. N. & Vaughan, T. L. Central adiposity and risk of Barrett’s esophagus. Gastroenterology 133, 403–411 (2007).
  Article PubMed Google Scholar
• Anderson, L. A. et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J. Gastroenterol. 13, 1585–1594 (2007).
  Article PubMed PubMed Central Google Scholar
• Kubo, A. et al. Cigarette smoking and the risk of Barrett’s esophagus. Cancer Causes Control. 20, 303–311 (2009).
  Article PubMed Google Scholar
• Thrift, A. P., Kramer, J. R., Richardson, P. A. & El-Serag, H. B. No significant effects of smoking or alcohol consumption on risk of Barrett’s esophagus. Dig. Dis. Sci. 59, 108–116 (2014).
  Article CAS PubMed Google Scholar
• Hardikar, S. et al. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett’s esophagus. PLoS ONE 8, e52192 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Coleman, H. G. et al. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett’s esophagus. Gastroenterology 142, 233–240 (2012).
  Article PubMed Google Scholar
• Ramus, J. R., Gatenby, P. A., Caygill, C. P., Watson, A. & Winslet, M. C. The relationship between smoking and severe dysplastic disease in patients with Barrett’s columnar-lined oesophagus. Eur. J. Cancer Prev. 21, 507–510 (2012).
  Article PubMed Google Scholar
• Kong, C. Y. et al. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol. Biomarkers Prev. 20, 2450–2456 (2011).
  Article PubMed PubMed Central Google Scholar
• Kroep, S. et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am. J. Gastroenterol. 109, 336–343 (2014).
  Article CAS PubMed Google Scholar
• Hoyo, C. et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium. Int. J. Epidemiol. 41, 1706–1718 (2012).
  Article PubMed PubMed Central Google Scholar
• Steffen, A. et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 137, 646–657 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Lindkvist, B. et al. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer 14, 103 (2014).
  Article PubMed PubMed Central Google Scholar
• El-Serag, H. The association between obesity and GERD: a review of the epidemiological evidence. Dig. Dis. Sci. 53, 2307–2312 (2008).
  Article PubMed PubMed Central Google Scholar
• Thrift, A. P. et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J. Natl Cancer Inst. 106, dju252 (2014).
  Article PubMed PubMed Central Google Scholar
• Coleman, H. G., Xie, S. H. & Lagergren, J. The epidemiology of esophageal adenocarcinoma. Gastroenterology 154, 390–405 (2018).
  Article PubMed Google Scholar
• Cook, M. B., Freedman, N. D., Gamborg, M., Sorensen, T. I. & Baker, J. L. Childhood body mass index in relation to future risk of oesophageal adenocarcinoma. Br. J. Cancer 112, 601–607 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Levi, Z. et al. Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer 119, 4086–4093 (2013).
  Article PubMed Google Scholar
• Singh, S. et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 1399–1412 (2013).
  Article PubMed Google Scholar
• Kubo, A. et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s oesophagus: a pooled analysis from the international BEACON consortium. Gut 62, 1684–1691 (2013).
  Article PubMed Google Scholar
• El-Serag, H. B. et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut 63, 220–229 (2014).
  Article PubMed Google Scholar
• Kendall, B. J., Macdonald, G. A., Prins, J. B., O’Brien, S. & Whiteman, D. C. Total body fat and the risk of Barrett’s oesophagus – a bioelectrical impedance study. Cancer Epidemiol. 38, 266–272 (2014).
  Article PubMed PubMed Central Google Scholar
• Thrift, A. P., Kramer, J. R., Alsarraj, A. & El-Serag, H. B. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J. Clin. Gastroenterol. 48, 218–223 (2014).
  Article PubMed PubMed Central Google Scholar
• Kendall, B. J. et al. Inverse association between gluteofemoral obesity and risk of Barrett’s esophagus in a pooled analysis. Clin. Gastroenterol. Hepatol. 14, 1412–1419 (2016).
  Article PubMed PubMed Central Google Scholar
• Lahmann, P. H., Pandeya, N., Webb, P. M., Green, A. C. & Whiteman, D. C. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer 118, 1901–1909 (2012).
  Article PubMed Google Scholar
• Freedman, N. D. et al. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON consortium. Gut 60, 1029–1037 (2011).
  Article PubMed PubMed Central Google Scholar
• Thrift, A. P. et al. Alcohol and the risk of Barrett’s esophagus: a pooled analysis from the international BEACON consortium. Am. J. Gastroenterol. 109, 1586–1594 (2014).
  Article PubMed PubMed Central Google Scholar
• Lou, Z., Xing, H. & Li, D. Alcohol consumption and the neoplastic progression in Barrett’s esophagus: a systematic review and meta-analysis. PLoS ONE 9, e105612 (2014).
  Article PubMed PubMed Central Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Oesophageal Cancer Project Expert Report (American Institute for Cancer Research, 2018).
• Pandeya, N., Williams, G., Green, A. C., Webb, P. M. & Whiteman, D. C. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 136, 1215–1224 (2009).
  Article CAS PubMed Google Scholar
• Crous-Bou, M., Jovani, M., De Vivo, I. & Jacobson, B. C. Gene-environment interactions and the risk of Barrett’s esophagus in three US cohorts. Am. J. Gastroenterol. 114, 893–899 (2019).
  Article PubMed PubMed Central Google Scholar
• Yokoyama, T. et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol. Biomarkers Prev. 12, 1227–1233 (2003).
  CAS PubMed Google Scholar
• Wilson, L. F. et al. The impact of reducing alcohol consumption in Australia: an estimate of the proportion of potentially avoidable cancers 2013-2037. Int. J. Cancer 145, 2944–2953 (2019).
  Article CAS PubMed Google Scholar
• Steck, S. E. & Murphy, E. A. Dietary patterns and cancer risk. Nat. Rev. Cancer 20, 125–138 (2020).
  Article CAS PubMed Google Scholar
• Rezende, L. F. M. et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br. J. Sports Med. 52, 826–833 (2018).
  Article PubMed Google Scholar
• Ibiebele, T. I., Hughes, M. C., Whiteman, D. C. & Webb, P. M. Dietary patterns and risk of oesophageal cancers: a population-based case-control study. Br. J. Nutr. 107, 1207–1216 (2012).
  Article CAS PubMed Google Scholar
• Kubo, A. et al. Dietary patterns and the risk of Barrett’s esophagus. Am. J. Epidemiol. 167, 839–846 (2008).
  Article PubMed PubMed Central Google Scholar
• Kubo, A. et al. Dietary antioxidants, fruits, and vegetables and the risk of Barrett’s esophagus. Am. J. Gastroenterol. 103, 1614–1623 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Li, W. Q. et al. Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study. Clin. Gastroenterol. Hepatol. 11, 1130–1136 (2013).
  Article PubMed PubMed Central Google Scholar
• Steevens, J., Schouten, L. J., Goldbohm, R. A. & van den Brandt, P. A. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Int. J. Cancer 129, 2681–2693 (2011).
  Article CAS PubMed Google Scholar
• Terry, P., Lagergren, J., Hansen, H., Wolk, A. & Nyren, O. Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur. J. Cancer Prev. 10, 365–369 (2001).
  Article CAS PubMed Google Scholar
• Thompson, O. M., Beresford, S. A., Kirk, E. A. & Vaughan, T. L. Vegetable and fruit intakes and risk of Barrett’s esophagus in men and women. Am. J. Clin. Nutr. 89, 890–896 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Li, N. et al. Dietary sugar/starches intake and Barrett’s esophagus: a pooled analysis. Eur. J. Epidemiol. 32, 1007–1017 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Sun, L., Zhang, Z., Xu, J., Xu, G. & Liu, X. Dietary fiber intake reduces risk for Barrett’s esophagus and esophageal cancer. Crit. Rev. Food Sci. Nutr. 57, 2749–2757 (2017).
  Article CAS PubMed Google Scholar
• Sharp, L., Carsin, A. E., Cantwell, M. M., Anderson, L. A. & Murray, L. J. Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett’s esophagus, and reflux esophagitis. J. Nutr. 143, 1966–1973 (2013).
  Article CAS PubMed Google Scholar
• Keszei, A. P., Goldbohm, R. A., Schouten, L. J., Jakszyn, P. & van den Brandt, P. A. Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am. J. Clin. Nutr. 97, 135–146 (2013).
  Article CAS PubMed Google Scholar
• Behrens, G. et al. The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis. Eur. J. Epidemiol. 29, 151–170 (2014).
  Article PubMed Google Scholar
• Singh, S., Devanna, S., Edakkanambeth Varayil, J., Murad, M. H. & Iyer, P. G. Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 14, 101 (2014).
  Article PubMed PubMed Central Google Scholar
• Petrick, J. L. et al. Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR study. PLoS ONE 13, e0190325 (2018).
  Article PubMed PubMed Central Google Scholar
• Cook, M. B. et al. Association between circulating levels of sex steroid hormones and Barrett’s esophagus in men: a case-control analysis. Clin. Gastroenterol. Hepatol. 13, 673–682 (2015).
  Article CAS PubMed Google Scholar
• Cook, M. B. et al. Sex steroid hormones in relation to Barrett’s esophagus: an analysis of the FINBAR study. Andrology 5, 240–247 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Petrick, J. L. et al. Associations between prediagnostic concentrations of circulating sex steroid hormones and esophageal/gastric cardia adenocarcinoma among men. J. Natl Cancer Inst. 111, 34–41 (2019).
  Article PubMed Google Scholar
• Petrick, J. L. & Cook, M. B. Do sex hormones underlie sex differences in cancer incidence? Testing the intuitive in esophageal adenocarcinoma. Am. J. Gastroenterol. 115, 211–213 (2020).
  Article PubMed PubMed Central Google Scholar
• Xie, S. H. et al. Circulating sex hormone levels and risk of esophageal adenocarcinoma in a prospective study in men. Am. J. Gastroenterol. 115, 216–223 (2020).
  Article PubMed Google Scholar
• Xie, S. H. et al. Association between levels of hormones and risk of esophageal adenocarcinoma and Barrett’s esophagus. Clin. Gastroenterol. Hepatol. 18, 2701–2709.e3 (2020).
  Article CAS PubMed Google Scholar
• Lagergren, K., Lagergren, J. & Brusselaers, N. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis. Int. J. Cancer 135, 2183–2190 (2014).
  Article CAS PubMed Google Scholar
• Cronin-Fenton, D. P. et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur. J. Cancer 46, 2067–2076 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Freedman, N. D. et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer 116, 1572–1581 (2010).
  Article PubMed PubMed Central Google Scholar
• Bodelon, C. et al. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev. Res. 4, 840–850 (2011).
  Article Google Scholar
• Lu, Y. & Lagergren, J. Reproductive factors and risk of oesophageal cancer, a population-based nested case-control study in Sweden. Br. J. Cancer 107, 564–569 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Parsonnet, J. et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127–1131 (1991).
  Article CAS PubMed Google Scholar
• Nie, S., Chen, T., Yang, X., Huai, P. & Lu, M. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis. Esophagus 27, 645–653 (2014).
  Article CAS PubMed Google Scholar
• Xie, F. J. et al. Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J. Gastroenterol. 19, 6098–6107 (2013).
  Article PubMed PubMed Central Google Scholar
• Wang, Z. et al. Helicobacter pylori infection is associated with reduced risk of Barrett’s esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium. Am. J. Gastroenterol. 113, 1148–1155 (2018).
  Article PubMed Google Scholar
• Eross, B. et al. Helicobacter pylori infection reduces the risk of Barrett’s esophagus: a meta-analysis and systematic review. Helicobacter 23, e12504 (2018).
  Article PubMed PubMed Central Google Scholar
• Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G. & El-Serag, H. B. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut 63, 1229–1237 (2014).
  Article PubMed Google Scholar
• Jankowski, J. A. Z. et al. Esomeprazole and aspirin in Barrett’s oesophagus (AspECT): a randomised factorial trial. Lancet 392, 400–408 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Tan, M. C., El-Serag, H. B., Yu, X. & Thrift, A. P. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett’s oesophagus: a nested case-control study in US male veterans. Aliment. Pharmacol. Ther. 48, 469–477 (2018).
  Article CAS PubMed Google Scholar
• Liao, L. M. et al. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology 142, 442–452 (2012).
  Article CAS PubMed Google Scholar
• Thrift, A. P. et al. Nonsteroidal anti-inflammatory drug use is not associated with reduced risk of Barrett’s esophagus. Am. J. Gastroenterol. 111, 1528–1535 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Vaughan, T. L. et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: a prospective study. Lancet Oncol. 6, 945–952 (2005).
  Article CAS PubMed Google Scholar
• Choi, S. E., Perzan, K. E., Tramontano, A. C., Kong, C. Y. & Hur, C. Statins and aspirin for chemoprevention in Barrett’s esophagus: results of a cost-effectiveness analysis. Cancer Prev. Res. 7, 341–350 (2014).
  Article CAS Google Scholar
• Sadeghi, S. et al. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiol. Biomarkers Prev. 17, 1169–1178 (2008).
  Article CAS PubMed Google Scholar
• Farrow, D. C. et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 7, 97–102 (1998).
  CAS PubMed Google Scholar
• Alexandre, L. et al. Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis. Gastroenterology 146, 661–668 (2014).
  Article CAS PubMed Google Scholar
• Beales, I. L., Vardi, I., Dearman, L. & Broughton, T. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study. Dis. Esophagus 26, 838–846 (2013).
  Article CAS PubMed Google Scholar
• Nguyen, T., Khalaf, N., Ramsey, D. & El-Serag, H. B. Statin use is associated with a decreased risk of Barrett’s esophagus. Gastroenterology 147, 314–323 (2014).
  Article CAS PubMed Google Scholar
• Nguyen, T., Duan, Z., Naik, A. D., Kramer, J. R. & El-Serag, H. B. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett’s esophagus: a nested case-control study. Gastroenterology 149, 1392–1398 (2015).
  Article CAS PubMed Google Scholar
• Beales, I. L., Dearman, L., Vardi, I. & Loke, Y. Reduced risk of Barrett’s esophagus in statin users: case-control study and meta-analysis. Dig. Dis. Sci. 61, 238–246 (2016).
  Article CAS PubMed Google Scholar
• Singh, S., Singh, A. G., Singh, P. P., Murad, M. H. & Iyer, P. G. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 620–629 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Verbeek, R. E. et al. Familial clustering of Barrett’s esophagus and esophageal adenocarcinoma in a European cohort. Clin. Gastroenterol. Hepatol. 12, 1656–1663.e1 (2014).
  Article PubMed Google Scholar
• Fecteau, R. E. et al. Association between germline mutation in VSIG10L and familial barrett neoplasia. JAMA Oncol. 2, 1333–1339 (2016).
  Article PubMed PubMed Central Google Scholar
• Blaydon, D. C. et al. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am. J. Hum. Genet. 90, 340–346 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Becker, J. et al. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma. Cancer Med. 4, 1700–1704 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Palles, C. et al. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus. Gastroenterology 148, 367–378 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Levine, D. M. et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett’s esophagus. Nat. Genet. 45, 1487–1493 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gharahkhani, P. et al. Genome-wide association studies in oesophageal adenocarcinoma and Barrett’s oesophagus: a large-scale meta-analysis. Lancet Oncol. 17, 1363–1373 (2016).
  Article PubMed PubMed Central Google Scholar
• Su, Z. et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus. Nat. Genet. 44, 1131–1136 (2012).
  Article CAS PubMed Google Scholar
• Lee, E. et al. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol. Biomarkers Prev. 24, 1801–1803 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Abnet, C. C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 42, 764–767 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Abnet, C. C. et al. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum. Mol. Genet. 21, 2132–2141 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, L. D. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 42, 759–763 (2010).
  Article CAS PubMed Google Scholar
• Wu, C. et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet. 43, 679–684 (2011).
  Article CAS PubMed Google Scholar
• Wu, C. et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat. Genet. 46, 1001–1006 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, C. et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat. Genet. 44, 1090–1097 (2012).
  Article CAS PubMed Google Scholar
• Corley, D. A. et al. Impact of endoscopic surveillance on mortality from Barrett’s esophagus-associated esophageal adenocarcinomas. Gastroenterology 145, 312–319 (2013).
  Article PubMed PubMed Central Google Scholar
• El-Serag, H. B. et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut 65, 1252–1260 (2016).
  Article PubMed Google Scholar
• Bhat, S. K. et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett’s oesophagus: a population-based study. Gut 64, 20–25 (2015).
  Article PubMed Google Scholar
• Wenker, T. N., Tan, M. C., Liu, Y., El-Serag, H. B. & Thrift, A. P. Prior diagnosis of Barrett’s esophagus is infrequent, but associated with improved esophageal adenocarcinoma survival. Dig. Dis. Sci. 63, 3112–3119 (2018).
  Article PubMed Google Scholar
• Gupta, M. et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology 145, 79–86.e71 (2013).
  Article PubMed PubMed Central Google Scholar
• Orman, E. S., Li, N. & Shaheen, N. J. Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 1245–1255 (2013).
  Article PubMed Google Scholar
• El-Serag, H. B. & Graham, D. Y. Routine polypectomy for colorectal polyps and ablation for Barrett’s esophagus are intellectually the same. Gastroenterology 140, 386–388 (2011).
  Article PubMed Google Scholar
• Hur, C. et al. The cost effectiveness of radiofrequency ablation for Barrett’s esophagus. Gastroenterology 143, 567–575 (2012).
  Article PubMed PubMed Central Google Scholar
• Gordon, L. G. et al. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett’s esophagus. Gastrointest. Endosc. 79, 242–256.e6 (2014).
  Article PubMed Google Scholar
• Ross-Innes, C. S. et al. Risk stratification of Barrett’s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol. Hepatol. 2, 23–31 (2017).
  Article PubMed Google Scholar
• Offman, J. et al. Barrett’s Oesophagus Trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer 18, 784 (2018).
  Article PubMed PubMed Central Google Scholar
• Thota, P. N. & Chak, A. Is mass screening for Barrett’s esophagus a myth or reality? Clin. Gastroenterol. Hepatol. 17, 610–612 (2019).
  Article PubMed Google Scholar
• Kumar, S. et al. Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma. Ann. Surg. 262, 981–990 (2015).
  Article PubMed Google Scholar
• Fitzgerald, R. C. et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett’s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 396, 333–344 (2020).
  Article PubMed PubMed Central Google Scholar
• Sami, S. S. et al. Acceptability, accuracy, and safety of disposable transnasal capsule endoscopy for Barrett’s esophagus screening. Clin. Gastroenterol. Hepatol. 17, 638–646.e1 (2019).
  Article PubMed Google Scholar
• Taylor, P. R., Abnet, C. C. & Dawsey, S. M. Squamous dysplasia–the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 22, 540–552 (2013).
  Article PubMed PubMed Central Google Scholar
• Domper Arnal, M. J., Ferrández Arenas, Á. & Lanas Arbeloa, Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol. 21, 7933–7943 (2015).
  Article PubMed PubMed Central Google Scholar
• Chen, Q. et al. Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China. Sci. Rep. 6, 35707 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Rubenstein, J. H. et al. Prediction of Barrett’s esophagus among men. Am. J. Gastroenterol. 108, 353–362 (2013).
  Article PubMed PubMed Central Google Scholar
• Thrift, A. P., Garcia, J. M. & El-Serag, H. B. A multibiomarker risk score helps predict risk for Barrett’s esophagus. Clin. Gastroenterol. Hepatol. 12, 1267–1271 (2014).
  Article PubMed Google Scholar
• Dong, J. et al. Determining risk of Barrett’s esophagus and esophageal adenocarcinoma based on epidemiologic factors and genetic variants. Gastroenterology 154, 1273–1281 (2018).
  Article CAS PubMed Google Scholar
• Rubenstein, J. H. et al. Validation and comparison of tools for selecting individuals to screen for Barrett’s esophagus and early neoplasia. Gastroenterology 158, 2082–2092 (2020).
  Article PubMed Google Scholar
• Thrift, A. P., Kendall, B. J., Pandeya, N., Vaughan, T. L. & Whiteman, D. C. A clinical risk prediction model for Barrett esophagus. Cancer Prev. Res. 5, 1115–1123 (2012).
  Article Google Scholar
• Rubenstein, J. H. & Thrift, A. P. Risk factors and populations at risk: selection of patients for screening for Barrett’s oesophagus. Best Pract. Res. Clin. Gastroenterol. 29, 41–50 (2015).
  Article PubMed Google Scholar
• Thrift, A. P., Kanwal, F. & El-Serag, H. B. Prediction models for gastrointestinal and liver diseases: too many developed, too few validated. Clin. Gastroenterol. Hepatol. 14, 1678–1680 (2016).
  Article PubMed Google Scholar
• Thrift, A. P., Vaughan, T. L., Anderson, L. A., Whiteman, D. C. & El-Serag, H. B. External validation of the Michigan Barrett’s Esophagus Prediction Tool. Clin. Gastroenterol. Hepatol. 15, 1124–1126 (2017).
  Article PubMed PubMed Central Google Scholar
• Ireland, C. J., Thrift, A. P. & Esterman, A. Risk prediction models for Barrett’s esophagus discriminate well and are generalizable in an external validation study. Dig. Dis. Sci. 65, 2992–2999 (2020).
  Article PubMed Google Scholar
• Thrift, A. P., Kendall, B. J., Pandeya, N. & Whiteman, D. C. A model to determine absolute risk for esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 11, 138–144 (2013).
  Article PubMed Google Scholar
• Kunzmann, A. T. et al. Information on genetic variants does not increase identification of individuals at risk of esophageal adenocarcinoma compared to clinical risk factors. Gastroenterology 156, 43–45 (2019).
  Article PubMed Google Scholar
• Kunzmann, A. T. et al. Model for identifying individuals at risk for esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 16, 1229–1236 (2018).
  Article PubMed Google Scholar
• Parasa, S. et al. Development and validation of a model to determine risk of progression of Barrett’s esophagus to neoplasia. Gastroenterology 154, 1282–1289 (2017).
  Article PubMed Google Scholar
• Kunzmann, A. T. et al. External validation of a model to determine risk of progression of Barrett’s oesophagus to neoplasia. Aliment. Pharmacol. Ther. 49, 1274–1281 (2019).
  Article PubMed Google Scholar
• Pohl, H., Sirovich, B. & Welch, H. G. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev. 19, 1468–1470 (2010).
  Article PubMed Google Scholar